Synthetic peptide, corresponding to amino acids 196-210 of Human APRIL.
- HL60 and Jurkat cell lysate.
Shipped at 4°C. Store at +4°C.
Preservative: 0.02% Sodium Azide
Concentration information loading...
Immunogen affinity purified
Immunizing Peptide (Blocking)
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
IHC-P: Use at a concentration of 10 µg/ml.
WB: Use at a concentration of 2 - 4 µg/ml. Predicted molecular weight: 27 kDa. Can be blocked with APRIL peptide (human)
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Cytokine that binds to TNFRSF13B/TACI and to TNFRSF17/BCMA. May be implicated in the regulation of tumor cell growth. May be involved in monocyte/macrophage-mediated immunological processes.
Expressed at high levels in transformed cell lines, cancers of colon, thyroid, lymphoid tissues and specifically expressed in monocytes and macrophages.
Belongs to the tumor necrosis factor family.
The precursor is cleaved by furin.
Information by UniProt
- A proliferation inducing ligand antibody
- A proliferation-inducing ligand antibody
- APRIL antibody
Western blot - Anti-APRIL antibody (ab3681)
Lane 1 : Anti-APRIL antibody (ab3681) at 1 µg/ml
Lane 2 : Anti-APRIL antibody (ab3681) at 2 µg/ml
Lane 3 : Anti-APRIL antibody (ab3681) at 4 µg/ml
All lanes : Jurkat cells
Predicted band size: 27 kDa
Observed band size: 27 kDa
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-APRIL antibody (ab3681)
Immunohistochemistry of APRIL in human prostate tissue with APRIL antibody at 10 µg/ml.
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"